Chinese FDA to Launch a Quality Consistency Evaluation for Generic Drugs


Chinese State Food and Drug Administration (“SFDA”) issued a draft Work Plan for Quality Consistency Evaluation for Generic Drugs (“Work Plan”) on November 22 for public comments through December 6. As part of the 12th Five-Year Plan for Drug Safety, the Work Plan aims at elimination of generic drugs which fail the quality consistency evaluation in order to enhance the overall quality standards of generic drugs.

The Quality Consistency Evaluation will focus on consistency of composition and clinical efficacy between the test and reference products. SFDA intends to pilot the Quality Consistency Evaluation on the solid oral dosage forms of essential drugs which have been applied widely in the patient population, with a large sales volume, produced by multiple manufacturers and that can be compared to a specific reference product.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ropes & Gray LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.